Articles

Pevonedistat and azacitidine upregulate NOXA (PMAIP1) to increase sensitivity to venetoclax in preclinical models of acute myeloid leukemia

Oncology Discovery, AbbVie, Inc
Department of Pediatrics; Medicine; Program in Cancer Biology, Vanderbilt University School of Medicine
Oncology Discovery, AbbVie, Inc
Medicine
Oncology Discovery, AbbVie, Inc
Oncology Discovery, AbbVie, Inc
Medicine
Precision Medicine, AbbVie Inc., 1 North Waukegan Rd., North Chicago, IL 60064
Medicine; Program in Cancer Biology, Vanderbilt University School of Medicine
Oncology Discovery, AbbVie, Inc
Oncology Discovery, AbbVie, Inc
Medicine; Program in Cancer Biology, Vanderbilt University School of Medicine; Vanderbilt-Ingram Cancer Center; Center for Immunobiology, Vanderbilt University School of Medicine, Nashville, TN 37232
Haematologica Early view Apr 15, 2021 https://doi.org/10.3324/haematol.2020.272609